tiprankstipranks
Advertisement
Advertisement

Mangoceuticals Amends Promissory Note with Indigo Capital

Story Highlights
Mangoceuticals Amends Promissory Note with Indigo Capital

Elevate Your Investing Strategy:

Mangoceuticals, Inc. ( (MGRX) ) has provided an announcement.

On May 23, 2025, Mangoceuticals, Inc. entered into Subscription Agreements with two accredited investors, resulting in the issuance of 70,454 shares of common stock and warrants to purchase 35,227 shares, raising $116,249. The Investor Warrants have specific exercise conditions and beneficial ownership limitations. Additionally, on May 27, 2025, the company amended a previous promissory note with Indigo Capital LP, allowing conversion into common stock and removing mandatory prepayment requirements. Furthermore, Mangoceuticals entered a digital marketing agreement with Levo Healthcare Consulting, Inc., issuing 120,000 shares of restricted common stock in exchange for services starting June 1, 2025. These strategic financial moves aim to enhance the company’s capital structure and marketing capabilities.

More about Mangoceuticals, Inc.

Average Trading Volume: 283,338

Technical Sentiment Signal: Sell

Current Market Cap: $26.7M

See more data about MGRX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1